68497-62-1,MFCD27977197
Catalog No.:AA0039CT

68497-62-1 | Pramiracetam

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$29.00   $21.00
- +
1g
98%
in stock  
$68.00   $48.00
- +
5g
98%
in stock  
$220.00   $154.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0039CT
Chemical Name:
Pramiracetam
CAS Number:
68497-62-1
Molecular Formula:
C14H27N3O2
Molecular Weight:
269.3831
MDL Number:
MFCD27977197
SMILES:
O=C(CN1CCCC1=O)NCCN(C(C)C)C(C)C
Properties
Computed Properties
 
Complexity:
308  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
7  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0.8  

Synonyms
 
  
Literature

Title: [Platelet hyperreactivity and antiaggregatory properties of nootropic drugs under conditions of alloxan-induced diabetes in rats].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20120101

Title: Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.

Journal: Drugs 20100212

Title: Diisoprop-yl{2-[2-(2-oxopyrrolidin-1-yl)acetamido]eth-yl}ammonium hydrogen sulfate.

Journal: Acta crystallographica. Section E, Structure reports online 20080601

Title: [Application of nootropic agents in complex treatment of patients with concussion of the brain].

Journal: Likars'ka sprava 20070101

Title: Brahmi rasayana improves learning and memory in mice.

Journal: Evidence-based complementary and alternative medicine : eCAM 20060301

Title: [Experience in the application of pramistar, a new nootropic preparation, in the treatment of memory disorders in patients with cerebrovascular pathology].

Journal: Likars'ka sprava 20031201

Title: Therapeutic approaches to age-associated neurocognitive disorders.

Journal: Dialogues in clinical neuroscience 20010901

Title: Warner Lambert, et al. Some Neurochemical Properties of Pramiracetam (CI-879), A New Cognition-Enhancing Agent.

Title: Chang T, et al. Pharmacokinetics of oral pramiracetam in normal volunteers. J Clin Pharmacol. 1985 May-Jun;25(4):291-5.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:68497-62-1 Molecular Formula|68497-62-1 MDL|68497-62-1 SMILES|68497-62-1 Pramiracetam
Catalog No.: AA0039CT
68497-62-1,MFCD27977197
68497-62-1 | Pramiracetam
Pack Size: 250mg
Purity: 98%
in stock
$29.00 $21.00
Pack Size: 1g
Purity: 98%
in stock
$68.00 $48.00
Pack Size: 5g
Purity: 98%
in stock
$220.00 $154.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0039CT
Chemical Name: Pramiracetam
CAS Number: 68497-62-1
Molecular Formula: C14H27N3O2
Molecular Weight: 269.3831
MDL Number: MFCD27977197
SMILES: O=C(CN1CCCC1=O)NCCN(C(C)C)C(C)C
Properties
Complexity: 308  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 19  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 7  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0.8  
64:   
Literature fold

Title: [Platelet hyperreactivity and antiaggregatory properties of nootropic drugs under conditions of alloxan-induced diabetes in rats].

Journal: Eksperimental'naia i klinicheskaia farmakologiia20120101

Title: Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.

Journal: Drugs20100212

Title: Diisoprop-yl{2-[2-(2-oxopyrrolidin-1-yl)acetamido]eth-yl}ammonium hydrogen sulfate.

Journal: Acta crystallographica. Section E, Structure reports online20080601

Title: [Application of nootropic agents in complex treatment of patients with concussion of the brain].

Journal: Likars'ka sprava20070101

Title: Brahmi rasayana improves learning and memory in mice.

Journal: Evidence-based complementary and alternative medicine : eCAM20060301

Title: [Experience in the application of pramistar, a new nootropic preparation, in the treatment of memory disorders in patients with cerebrovascular pathology].

Journal: Likars'ka sprava20031201

Title: Therapeutic approaches to age-associated neurocognitive disorders.

Journal: Dialogues in clinical neuroscience20010901

Title: Warner Lambert, et al. Some Neurochemical Properties of Pramiracetam (CI-879), A New Cognition-Enhancing Agent.

Title: Chang T, et al. Pharmacokinetics of oral pramiracetam in normal volunteers. J Clin Pharmacol. 1985 May-Jun;25(4):291-5.

Building Blocks More >
40054-69-1
40054-69-1
4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
AA0039GG | MFCD00867532
154445-77-9
154445-77-9
Fmoc-Arg(Pbf)-OH
AA0039JL | MFCD00235804
473932-16-0
473932-16-0
Quinoxaline-6-acetic acid
AA0039MW | MFCD09880609
1188910-76-0
1188910-76-0
CEP-32496
AA0039PW | MFCD22124524
27262-47-1
27262-47-1
Levobupivacaine
AA0039TA | MFCD00936851
137130-65-5
137130-65-5
Boc-D-Asp-OMe
AA0039X1 | MFCD03094776
10354-53-7
10354-53-7
N-Phenylpicolinamide
AA003A1C | MFCD00511984
223671-71-4
223671-71-4
1-Chloroisoquinoline-5-carboxylic acid hydrochloride
AA003A4X | MFCD13151993
1092351-96-6
1092351-96-6
Methyl 2-bromooxazole-5-carboxylate
AA003A8E | MFCD11109415
24367-94-0
24367-94-0
N-[4-[(4-Aminophenyl)methyl]phenyl]acetamide
AA003ACP | MFCD02752271
Submit
© 2017 AA BLOCKS, INC. All rights reserved.